Total Revenue (USD)

Cost of Goods Sold (COGS) (USD)

Selling, General, and Administrative Expenses (SG&A) (USD)

Research and Development (R&D) (USD)

Depreciation and Amortization (D&A) (USD)

Interest Expense (USD)

Operating Income (EBIT) (USD)

Net Income (USD)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

4a57b6e4e053ee19c1f9fb8fe754c8afb9701fe61efbfb9a1dfb3d7a080e8bb0

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

607f5e93bb6c00428ce67a413b5e0db5562448e1e791d4b7e96cc8d398a4c59f

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

f87e1d906ca4655697867c2c31db1204ae9c9d85b43b8e0ec04d1423b92406e1

Net loss (USD, thousands)

Depreciation (USD, thousands)

Amortization of intangible assets (USD, thousands)

Amortization of right-of-use lease assets / Noncash lease expense (USD, thousands)

Amortization of debt issuance costs (USD, thousands)

Deferred income tax benefit (USD, thousands)

Loss (gain) on disposal of fixed assets (USD, thousands)

Stock-based compensation (USD, thousands)

Unrealized foreign currency losses (gains) (USD, thousands)

(Amortization of premium) accretion of discount on short-term investments (USD, thousands)

Other liabilities (Adjustment to Net Loss) (USD, thousands)

Acquired in-process R&D acquired through the issuance of common stock (USD, thousands)

Changes in operating assets and liabilities: Accounts receivable, net (USD, thousands)

Changes in operating assets and liabilities: Inventory (USD, thousands)

Changes in operating assets and liabilities: Prepaid expenses and other current assets (USD, thousands)

Changes in operating assets and liabilities: Accounts payable and accrued liabilities (USD, thousands)

Changes in operating assets and liabilities: Other assets (USD, thousands)

Net cash used in operating activities (USD, thousands)

Investing activities: Purchases of property and equipment (USD, thousands)

Investing activities: Purchases of short-term investments (USD, thousands)

Investing activities: Proceeds from sales and maturities of short-term investments (USD, thousands)

Investing activities: Investment in company-owned life insurance (USD, thousands)

Financing activities: Proceeds from exercise of stock options (USD, thousands)

Financing activities: Proceeds from share purchases under Employee Stock Purchase Plan (USD, thousands)

Financing activities: Payments of employee taxes related to vested restricted stock units (USD, thousands)

Financing activities: Principal paid on finance lease (USD, thousands)

Net cash provided by financing activities (USD, thousands)

Effect of exchange rate changes on cash and cash equivalents (USD, thousands)

Net increase (decrease) in cash, cash equivalents and restricted cash (USD, thousands)

Supplemental disclosures: Taxes paid, net of refunds (USD, thousands)

Supplemental disclosures: Other interest paid (USD, thousands)

Cash, cash equivalents and restricted cash at beginning of period (USD, thousands)

Cash, cash equivalents and restricted cash at end of period (USD, thousands)

004aece33aba4f48e1b5d8a6a3c11e21f2280ac5dcd248d782a48a669889b871

Net sales (USD, thousands)

Cost of sales (USD, thousands)

Gross profit (USD, thousands)

Selling, general and administrative (USD, thousands)

Research and development (USD, thousands)

Acquired in-process research and development (USD, thousands)

Total operating expenses (USD, thousands)

Loss from operations (USD, thousands)

Interest income (USD, thousands)

Interest expense (USD, thousands)

Other income (expense), net (USD, thousands)

Total non-operating income (expense) (USD, thousands)

Loss before taxes (USD, thousands)

Income tax provision (USD, thousands)

Basic and diluted net loss per share (USD)

Weighted-average shares outstanding used to compute basic and diluted net loss per share (thousands)

acfe7eb01a55ad8edb5d5bbaa0c5f3384703b4200526df8964e244f973a9275e

Cash and cash equivalents (USD, thousands)

Short-term investments (USD, thousands)

Accounts receivable, net (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Restricted cash (USD, thousands)

Property and equipment, net (USD, thousands)

Operating lease right-of-use asset (USD, thousands)

Finance lease right-of-use asset (USD, thousands)

Intangible assets, net (USD, thousands)

Deposits and other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Operating lease liability (USD, thousands)

Finance lease liability (USD, thousands)

Deferred tax liability, net (USD, thousands)

Other liabilities (USD, thousands)

Total liabilities (USD, thousands)

Preferred stock (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (USD, thousands)

Accumulated deficit (USD, thousands)

Less treasury stock (USD, thousands)

Total stockholders' equity (USD, thousands)

Total liabilities and stockholders' equity (USD, thousands)

3470f937d17228ed60fbdcf41b2ccd601fce0ea99d5078711d32d98b733cbbd6

Glaukos Corp (GKOS)

Financials